Skip to main content

Antifungal Susceptibility Testing Methods: Non-CLSI Methods for Yeast and Moulds

  • Chapter
  • First Online:
Interactions of Yeasts, Moulds, and Antifungal Agents

Abstract

There are defined methods for performing susceptibility testing that have been published by the Clinical and Laboratory Standards Institute (CLSI) for yeast and moulds. There are commercially available products for performance of the recommended broth microdilution methods that are contained in those documents. These are described in Chapter 2 of this text. In addition, there are other available methods that are described in this chapter that are culture-based and non-culture-based. These include the use of disk diffusion, Etest, chromogenic media, and molecular methods.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Alexander BD, Byrne TC, Smith KL, Hanson KE, Anstrom KJ, Perfect JR, Reller LB (2007) Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J Clin Microbiol 45:698–706

    Article  PubMed  CAS  Google Scholar 

  2. Antachopoulos C, Meletiadis J, Roilides E, Sein T, Walsh TJ (2006) Rapid susceptibility testing of medically important zygomycetes by XTT assay. J Clin Microbiol 44:553–560

    Article  PubMed  CAS  Google Scholar 

  3. Arthington-Skaggs BA, Jradi H, Desai T, Morrison CJ (1999) Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 37:3332–3337

    PubMed  CAS  Google Scholar 

  4. Balajee SA, Imhof A, Gribskov JL, Marr KA (2005) Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay. J Antimicrob Chemother 55:102–105

    Article  PubMed  CAS  Google Scholar 

  5. Balajee SA, Marr KA (2002) Conidial viability assay for rapid susceptibility testing of Aspergillus species. J Clin Microbiol 40:2741–2745

    Article  PubMed  CAS  Google Scholar 

  6. Balashov SV, Park S, Perlin DS (2006) Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1. Antimicrob Agents Chemother 50:2058–2063

    Article  PubMed  CAS  Google Scholar 

  7. Barry AL, Pfaller MA, Rennie RP, Fuchs PC, Brown SD (2002) Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob Agents Chemother 46:1781–1784

    Article  PubMed  CAS  Google Scholar 

  8. Bolmström A, Arvidson S, Ericsson M, Karlsson A (1988) A Novel Technique for direct quantification of antimicrobial susceptibility of microorganisms. Poster 1209 ICAAC, Los Angeles

    Article  PubMed  CAS  Google Scholar 

  9. Cuenca-Estrella M, Moore CB, Barchiesi F, Bille J, Chryssanthou E, Denning DW, Donnelly JP, Dromer F, Dupont B, Rex JH, Richardson MD, Sancak B, Verweij PE, Rodriguez-Tudela JL (2003) Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect 9:467–474

    Article  PubMed  CAS  Google Scholar 

  10. Davey KG, Holmes AD, Johnson EM, Szekely A, Warnock DW (1998) Comparative evaluation of FUNGITEST and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. J Clin Microbiol 36:926–930

    PubMed  CAS  Google Scholar 

  11. Espinel-Ingroff A (2006) Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B. J Clin Microbiol 44:3616–3622

    Article  PubMed  CAS  Google Scholar 

  12. Espinel-Ingroff A, Pfaller M, Messer SA, Knapp CC, Killian S, Norris HA, Ghannoum MA (1999) Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms. J Clin Microbiol 37:591–595

    PubMed  CAS  Google Scholar 

  13. Guinea J, Pelaez T, Alcala L, Bouza E (2007) Correlation between the Etest and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus. Diagn Microbiol Infect Dis 57:273–276

    Article  PubMed  CAS  Google Scholar 

  14. Imhof A, Balajee SA, Marr KA (2003) New methods to assess susceptibilities of Aspergillus isolates to caspofungin. J Clin Microbiol 41:5683–5688

    Article  PubMed  CAS  Google Scholar 

  15. Kartsonis N, Killar J, Mixson L, Hoe CM, Sable C, Bartizal K, Motyl M (2005) Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome. Antimicrob Agent Chemother 49:3616–3623

    Article  PubMed  CAS  Google Scholar 

  16. Lewis RE, Diekema DJ, Messer SA, Pfaller MA, Klepser ME (2002) Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J Antimicrob Chemother 49:345–351

    Article  PubMed  CAS  Google Scholar 

  17. Liao RS, Rennie RP, Talbot JA (2001) Novel fluorescent broth microdilution method for fluconazole susceptibility testing of Candida albicans. J Clin Microbiol 39:2708–2712

    Article  PubMed  CAS  Google Scholar 

  18. Maxwell MJ, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA (2003) Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans. J Clin Microbiol 41:97–99

    Article  PubMed  CAS  Google Scholar 

  19. Messer SA, Diekema DJ, Hollis RJ, Boyken LB, Tendolkar S, Kroeger J, Pfaller MA (2007) Evaluation of disk diffusion and Etest compared to broth microdilution antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi. J Clin Microbiol 45:1322–1324

    Article  PubMed  CAS  Google Scholar 

  20. Morace G, Amato G, Bistoni F, Fadda G, Marone P, Montagna MT, Oliveri S, Polonelli L, Rigoli R, Mancuso I, La Face S, Masucci L, Romano L, Napoli C, Tato D, Buscema MG, Belli CMC, Piccirillo MM, Conti S, Covan S, Fanti F, Cavanna C, D’Alo F, Pitzurra L (2002) Multicenter comparative evaluation of six commercial systems and the National Committee for Clinical Laboratory Standards M27-A broth microdilution method for fluconazole susceptibility testing of Candida species. J Clin Microbiol 40:2953–2958

    Article  PubMed  CAS  Google Scholar 

  21. Mukherjee PK, Sheehan DJ, Hitchcock CA, Ghannoum MA (2005) Combination treatment of invasive fungal infections. Clin Microbiol Rev 18:163–194

    Article  PubMed  CAS  Google Scholar 

  22. NCCLS (2004) Reference method for antifungal disk diffusion susceptibility testing of yeasts, approved standard. NCCLS, Wayne

    Google Scholar 

  23. NCCLS (2002) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, approved standard. NCCLS, Wayne

    Google Scholar 

  24. NCCLS (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 2nd edn. NCCLS, Wayne

    Google Scholar 

  25. Park S, Perlin DS (2005) Establishing surrogate markers for fluconazole resistance in Candida albicans. Microb Drug Resist 11:232–238

    Article  PubMed  CAS  Google Scholar 

  26. Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, Diekema DJ (2004) Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans. Diagn Microbiol Infect Dis 50:113–117

    Article  PubMed  CAS  Google Scholar 

  27. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG (2007) Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. J Clin Microbiol 45:796–802

    Article  PubMed  CAS  Google Scholar 

  28. Pfaller MA, Messer SA, Coffmann S (1995) Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870. J Clin Microbiol 33:1094–1097

    PubMed  CAS  Google Scholar 

  29. Pfaller MA, Messer SA, Mills K, Bolmstrom A (2000) In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs. J Clin Microbiol 38:3359–3361

    PubMed  CAS  Google Scholar 

  30. Pfaller MA, Messer SA, Mills K, Bolmstrom A, Jones RN (2001) Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species. J Clin Microbiol 39:4387–4389

    Article  PubMed  CAS  Google Scholar 

  31. Pfaller MA, Messer SA, Mills K, Bolmstrom A, Jones RN (2001) Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species. J Clin Microbiol 39:3952–3954

    Article  PubMed  CAS  Google Scholar 

  32. Pfaller MA, Sheehan DJ, Rex JH (2004) Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization. Clin Microbiol Rev 17:268–280

    Article  PubMed  CAS  Google Scholar 

  33. Philpot C (1993) Determination of sensitivity to antifungal drugs: evaluation of an API kit. Br J Biomed Sci 50:27–30

    PubMed  CAS  Google Scholar 

  34. Provine H, Hadley S (2000) Preliminary evaluation of a semisolid agar antifungal susceptibility test for yeasts and molds. J Clin Microbiol 38:537–541

    PubMed  CAS  Google Scholar 

  35. Ramani R, Chaturvedi V (2000) Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test. Antimicrob Agents Chemother 44:2752–2758

    Article  PubMed  CAS  Google Scholar 

  36. Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, Brass C, Vazquez JA, Chapman SW, Horowitz HW, Zervos M, McKinsey D, Lee J, Babinchak T, Bradsher RW, Cleary JD, Cohen DM, Danziger L, Goldman M, Goodman J, Hilton E, Hyslop NE, Kett DH, Lutz J, Rubin RH, Scheld WM, Schuster M, Simmons B, Stein DK, Washburn RG, Mautner L, Chu TC, Panzer H, Rosenstein RB, Booth J (2003) A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis 36:1221–1228

    Article  PubMed  CAS  Google Scholar 

  37. Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, Gosey LL, Odds FC, Rinaldi MG, Sheehan DJ, Warnock DW (2001) Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 14:643–658, table of contents

    Article  PubMed  CAS  Google Scholar 

  38. Ribeiro MA, Paula CR (2007) Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication? Diagn Microbiol Infect Dis 57:71–75

    Article  PubMed  CAS  Google Scholar 

  39. Riesselman MH, Hazen KC, Cutler JE (2000) Determination of antifungal MICs by a rapid susceptibility assay. J Clin Microbiol 38:333–340

    PubMed  CAS  Google Scholar 

  40. Sims CR, Paetznick VL, Rodriguez JR, Chen E, Ostrosky-Zeichner L (2006) Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp. J Clin Microbiol 44:2105–2108

    Article  PubMed  CAS  Google Scholar 

  41. Steinbach WJ, Stevens DA, Denning DW (2003) Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001. Clin Infect Dis 37(Suppl 3):S188–S224

    Article  PubMed  CAS  Google Scholar 

  42. Szekely A, Johnson EM, Warnock DW (1999) Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol 37:1480–1483

    PubMed  CAS  Google Scholar 

  43. Tan GL, Peterson EM (2005) CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures. J Clin Microbiol 43:1727–1731

    Article  PubMed  Google Scholar 

  44. van Eldere J, Joosten L, Verhaeghe V, Surmont I (1996) Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test. J Clin Microbiol 34:842–847

    PubMed  Google Scholar 

  45. Vandenbossche I, Vaneechoutte M, Vandevenne M, De Baere T, Verschraegen G (2002) Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-Test, and disk diffusion for application in the routine laboratory. J Clin Microbiol 40:918–921

    Article  PubMed  CAS  Google Scholar 

  46. Wanger A, Mills K, Nelson P, Rex J (1995) Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob Agents Chemother 39:2520–2522

    PubMed  CAS  Google Scholar 

  47. Willinger B, Engelmann E, Hofmann H, Metzger S, Apfalter P, Hirschl AM, Makristathis A, Rotter M, Raddatz B, Seibold M (2002) Multicenter comparison of Fungitest for susceptibility testing of Candida species. Diagn Microbiol Infect Dis 44:253–257

    Article  PubMed  CAS  Google Scholar 

  48. Xu J, Vilgalys R, Mitchell TG (1998) Colony size can be used to determine the MIC of fluconazole for pathogenic yeasts. J Clin Microbiol 36:2383–2385

    PubMed  CAS  Google Scholar 

  49. Zambardi G, Parreno D, Monnin V, Fothergill A, Hurt L, Bassel A, McCarthy D, Canard I, Slaughter J (2005) Presented at the interscience conference on antimicrobial agents and chemotherapy, Washington, DC. Rapid antifungal susceptibility testing of medically important yeasts with the VITEK 2 system

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Audrey Wanger Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Wanger, A. (2012). Antifungal Susceptibility Testing Methods: Non-CLSI Methods for Yeast and Moulds. In: Hall, G. (eds) Interactions of Yeasts, Moulds, and Antifungal Agents. Humana Press. https://doi.org/10.1007/978-1-59745-134-5_3

Download citation

Publish with us

Policies and ethics